Summary of MAPT
MAPT codes for a protein named tau which is involved in assembling and stabilizing microtubules. Microtubules help maintain cell shape, cell division, transportation of materials within cells (R).
Mutations in the MAPT gene can cause dementia and other brain disorders (R).
The Function of MAPT
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
Protein names
Recommended name:
Microtubule-associated protein tauAlternative name(s):
Neurofibrillary tangle proteinPaired helical filament-tau
PHF-tau
- RS1467967 (MAPT) ??
- RS17649553 (MAPT) ??
- RS17651507 (MAPT) ??
- RS1800547 (MAPT) ??
- RS1864325 (MAPT) ??
- RS1981997 (MAPT) ??
- RS2258689 (MAPT) ??
- RS242557 (MAPT) ??
- RS242559 (MAPT) ??
- RS242562 (MAPT) ??
- RS2435207 (MAPT) ??
- RS2471738 (MAPT) ??
- RS3785883 (MAPT) ??
- RS7521 (MAPT) ??
- RS8070723 (MAPT) ??
- RS9468 (MAPT) ??
To see your genotype, you should be logged in and have a file with your genotype uploaded.
Top Gene-Substance Interactions
MAPT Interacts with These Diseases
Disease | Score |
Substances That Increase MAPT
Substances | Interaction | Organism | Category |
Substances That Decrease MAPT
Substances | Interaction | Organism | Category |
Advanced Summary
MAPT codes for a protein named tau which is involved in assembling and stabilizing microtubules. Microtubules help maintain cell shape, cell division, transportation of materials within cells (R).
Mutations in the MAPT gene can cause dementia and other brain disorders (R).
frontotemporal dementia with parkinsonism-17 More than 40 mutations in the MAPT gene have been found to cause frontotemporal dementia with parkinsonism-17 (FTDP-17). Some of these mutations change single amino acids in the tau protein, most often in the microtubule-binding region. These mutations reduce tau's ability to bind to microtubules, which disrupts many important cell functions. Other MAPT gene mutations change the way the gene's instructions are used to build the tau protein. Most of these mutations increase the production of tau with four repeated segments compared to the production of tau with three repeated segments. The resulting imbalance of tau isoforms in the brain interferes with the normal functions of brain cells. In ways that are not fully understood, the MAPT gene mutations responsible for FTDP-17 lead to an accumulation of abnormal tau in neurons and other brain cells. These clumps of defective tau build up over time, although it is unclear what effect they have on cell function and survival. FTDP-17 is characterized by the gradual death of cells in areas of the brain called the frontal and temporal lobes. The frontal lobes are involved in reasoning, planning, judgment, and problem-solving, while the temporal lobes help process hearing, speech, memory, and emotion. The loss of cells in these brain regions leads to the major features of FTDP-17, including changes in personality and behavior, speech and language abnormalities, and problems with movement. progressive supranuclear palsy Several mutations in the MAPT gene have been found to cause progressive supranuclear palsy. However, mutations in this gene appear to be a rare cause of this disorder. At least one normal variation (polymorphism) in the MAPT gene has been associated with an increased risk of developing progressive supranuclear palsy. This polymorphism, known as the H1 haplotype, is found much more frequently in people with progressive supranuclear palsy than in the general population. It is unclear exactly how this genetic variation increases the risk of developing this disease. The features of progressive supranuclear palsy appear to be related to abnormalities in the tau protein. In people with MAPT gene mutations, genetic changes disrupt the protein's normal structure and function. However, abnormal tau is also found in people without MAPT gene mutations. The defective tau protein assembles into abnormal clumps within neurons and other brain cells, although it is unclear what effect these clumps have on cell function and survival. Progressive supranuclear palsy is characterized by the gradual death of brain cells, particularly in structures deep within the brain that are essential for coordinating movement. This loss of brain cells underlies the major features of progressive supranuclear palsy, including problems with movement, vision, speech, and thinking (cognition). other disorders Mutations in the MAPT gene have also been found to cause other brain disorders similar to FTDP-17 and progressive supranuclear palsy. These disorders include corticobasal degeneration, tauopathy with respiratory failure, and a form of dementia with seizures (epilepsy). Although these conditions have somewhat different patterns of signs and symptoms, they all involve changes in personality, behavior, or cognition and problems with movement. The MAPT gene mutations responsible for these disorders lead to a buildup of abnormal tau in brain cells. Although the effect of tau accumulation on cell function and survival is unknown, these disorders are characterized by the death of brain cells in regions of the brain essential for cognition, emotion, and coordinating movement. Because all of these diseases are characterized by an abnormal buildup of tau in the brain, they are known as tauopathies. Some researchers suggest that, instead of being described as separate disorders, the group of tauopathies caused by mutations in the MAPT gene should be considered as part of a spectrum with varying signs and symptoms.
The MAPT gene provides instructions for making a protein called tau. This protein is found throughout the nervous system, including in nerve cells (neurons) in the brain. It is involved in assembling and stabilizing microtubules, which are rigid, hollow fibers that make up the cell's structural framework (the cytoskeleton). Microtubules help cells maintain their shape, assist in the process of cell division, and are essential for the transport of materials within cells. Six different versions (isoforms) of the tau protein are produced in the adult brain. The isoforms vary in length from 352 to 441 protein building blocks (amino acids). A region of the protein called the microtubule-binding domain, which is the part of the protein that attaches (binds) to microtubules, also varies among the isoforms. In three of the isoforms, the microtubule-binding domain contains three repeated segments. In the other three isoforms, this domain contains four repeated segments. Typically, the brain has approximately the same amount of three-repeat isoforms and four-repeat isoforms. This balance appears to be essential for the normal function of neurons.
Conditions with Increased Gene Activity
Condition | Change (log2fold) | Comparison | Species | Experimental variables | Experiment name |
---|
Conditions with Decreased Gene Activity
Condition | Change (log2fold) | Comparison | Species | Experimental variables | Experiment name |
---|
Technical
The following transcription factors affect gene expression:
Tissue specificity:
Expressed in neurons. Isoform PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.
Gene Pathways:
Developmental stage:
Four-repeat (type II) TAU/MAPT is expressed in an adult-specific manner and is not found in fetal brain, whereas three-repeat (type I) TAU/MAPT is found in both adult and fetal brain.
Molecular Function:
- Apolipoprotein Binding
- Enzyme Binding
- Lipoprotein Particle Binding
- Microtubule Binding
- Sh3 Domain Binding
- Structural Constituent Of Cytoskeleton
Biological Processes:
- Adult Walking Behavior
- Axo-Dendritic Transport
- Axon Extension
- Generation Of Neurons
- Microtubule Cytoskeleton Organization
- Mitochondrion Transport Along Microtubule
- Negative Regulation Of Intracellular Transport
- Neuron Migration
- Positive Regulation Of Axon Extension
- Positive Regulation Of Microtubule Polymerization
- Regulation Of Autophagy
- Regulation Of Microtubule-Based Movement
- Regulation Of Microtubule Polymerization
- Brain Development
- Female Pregnancy
- Intrinsic Apoptotic Signaling Pathway In Response To Oxidative Stress
- Response To Nutrient
- Response To Organic Substance